DelabesseTeam
@DelabesseTeam
Followers
42
Following
6
Statuses
14
RT @LargeaudLaet: Happy to share our work about somatic alterations in GATA2 deficiency. Thanks to all members of…
0
6
0
RT @CHO_HEMATO: « Genetic and pharmacological HDAC3 inhibition is effective therapeutically against ERG dependent #Leukemia » Pr @ShaiIzra…
0
2
0
RT @CHO_HEMATO: About 120 researchers involved in #oncology and #hematopoiesis participate to the 28th @CHO_HEMATO meeting at @Belambra »…
0
23
0
RT @marlene_pasquet: Happy to share our lab work @DelabesseTeam @crctoncopole about #GATA2 deficiency in patients at #EHA2022 presented by…
0
3
0
RT @emmamgroarke: Interesting talk from Laetitia Largeaud at #EHA2022 looking at the clonal landscape of #GATA2. STAG2 predominates but may…
0
8
0
RT @crctoncopole: Visite du Député @DeputeCabareP au @crctoncopole pour decouvrir les travaux de @DelabesseTeam accompagné par l'associatio…
0
3
0
RT @crctoncopole: Marlène Pasquet from the IGAALD team of the @crctoncopole in partnership with @IUCTOncopoleICR and @IRIToulouse is the wi…
0
4
0
We are pleased to present our last publication in @BloodAdvances CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
0
2
4
Excellent talk from @LargeaudLaet from the @crctoncopole at #ASH21 on new approach to decipher GATA2 deficiency syndrome : focus on the recurrent GATA2 R396Q mutation
0
1
3
Excellent talk from @LargeaudLaet at #ASH21 on new approach to decipher GATA2 deficiency syndrome : focus on the recurrent GATA2 R396Q mutation
0
3
7
Happy to share our results on CADM1 as a candidate gene in MDS with del(11q) published in @BloodAdvances
0
4
3
RT @LargeaudLaet: Excited to announce the positive result of #interpedia grant from @Institut_cancer. Happy to have the opportunities to im…
0
4
0